store

  • KALA Amphipathic Peptide

    KALA Amphipathic Peptide

    Amount: 1 mg Application: Drug delivery Category: Cell-Penetrating Peptides Condition / Topic: Cancer, Gene therapy Layout: Freeze-dried in plastic vial Organism: Artificial Protein Name: CPP Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-WEAKLAKALAKALAKHLAKALAKALKA-OH

  • KAMP-19 Antimicrobial Peptide

    KAMP-19 Antimicrobial Peptide

    Amount: 0.5 mg Application: Proteomics Category: Antimicrobial Peptides Condition / Topic: Antimicrobial Layout: Freeze-dried in plastic vial Modification: None Organism: Human Protein Name: Keratin Purity: >95% (HPLC-MS) Quantification: No Sequence: H-RAIGGGLSSVGGGSSTIKY-OH Specifications: Antimicrobial peptide

  • Keratinocyte-associated protein 2 84-92, FASGLIHRV

    Keratinocyte-associated protein 2 84-92, FASGLIHRV

    Application: T-cell immunity Category: Antigen Peptides Layout: Freeze-dried in glass vial Organism: Human Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FASGLIHRV-OH Specifications: 9mer peptide as TFA salt

  • L.monocytogenes (LLO)

    L.monocytogenes (LLO)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Infection, Listeriosis Layout: Freeze-dried in glass vial Organism: Listeria monocytogenes Protein Name: Listeriolysin O Purity: >70% (HPLC-MS), Development Grade: each peptide purified to >…

  • L1-6 (PLILLRLLR)

    L1-6 (PLILLRLLR)

    Amount: 1 mg Application: Drug delivery Category: Cell-Penetrating Peptides Layout: Freeze-dried in plastic vial Organism: Artificial Protein Name: CPP Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-PLILLRLLR-NH2

  • LAH4-L1 Peptide

    LAH4-L1 Peptide

    Amount: 1 mg Application: Drug delivery Category: Cell-Penetrating Peptides Condition / Topic: Cancer, Gene therapy Layout: Freeze-dried in plastic vial Organism: Artificial Protein Name: CPP Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-KKALLAHALHLLALLALHLAHALKKA-NH2

  • Large ribosomal subunit protein eL6 276-288, ALTNGIYPHKLVF

    Large ribosomal subunit protein eL6 276-288, ALTNGIYPHKLVF

    Application: T-cell immunity Category: Antigen Peptides Layout: Freeze-dried in glass vial Organism: Human Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-ALTNGIYPHKLVF-OH Specifications: 13mer peptide as TFA salt

  • Lassa virus (Pre-glycoprotein complex)

    Lassa virus (Pre-glycoprotein complex)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Fever, Hemorrhagic fever, Infection, Lassa fever Layout: Freeze-dried in glass vial Organism: Lassa virus Protein Name: Pre-glycoprotein polyprotein GP complex Purity: >70% (HPLC-MS), Development…

  • LCMV (strain Armstrong) (LCMV) Nucleoprotein  205-212, YTVKYPNL

    LCMV (strain Armstrong) (LCMV) Nucleoprotein 205-212, YTVKYPNL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection, Lymphocytic choriomeningitis Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Lymphocytic choriomeningitis virus Protein Name: Nucleoprotein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YTVKYPNL-OH Specifications: 8mer peptide as TFA salt

  • LCMV (strain Armstrong) Nucleoprotein  118-126, RPQASGVYM

    LCMV (strain Armstrong) Nucleoprotein 118-126, RPQASGVYM

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Lymphocytic choriomeningitis Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Lymphocytic choriomeningitis virus Protein Name: Nucleoprotein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RPQASGVYM-OH Specifications: 9mer peptide as TFA salt

  • LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex  10-18, ALPHIIDEV

    LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex 10-18, ALPHIIDEV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Lymphocytic choriomeningitis virus Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-ALPHIIDEV-OH Specifications: 9mer peptide as TFA salt

  • LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex  118-125, ISHNFCNL

    LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex 118-125, ISHNFCNL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Lymphocytic choriomeningitis Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Lymphocytic choriomeningitis virus Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-ISHNFCNL-OH Specifications: 8mer peptide as TFA salt

  • LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex  447-455, YLVSIFLHL

    LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex 447-455, YLVSIFLHL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Lymphocytic choriomeningitis virus Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YLVSIFLHL-OH Specifications: 9mer peptide as TFA salt

  • LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex  92-101, CSANNSHHYI

    LCMV (strain Armstrong) Pre-glycoprotein polyprotein GP complex 92-101, CSANNSHHYI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Lymphocytic choriomeningitis Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Lymphocytic choriomeningitis virus Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-CSANNSHHYI-OH Specifications: 10mer peptide as TFA salt

  • LIM domain transcription factor LMO4 29-37, KIADRFLLY

    LIM domain transcription factor LMO4 29-37, KIADRFLLY

    Application: T-cell immunity Category: Antigen Peptides Layout: Freeze-dried in glass vial Organism: Human Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-KIADRFLLY-OH Specifications: 9mer peptide as TFA salt

  • Liraglutide Peptide (CAS 204656-20-2)

    Liraglutide Peptide (CAS 204656-20-2)

    Amount: 1.0 mg net (AAA) Application: Diabetes research Category: Diabetes Peptides Condition / Topic: Diabetes Layout: Freeze-dried in plastic vial Organism: Artificial Protein Name: Diabetes Peptide Purity: >95% (HPLC-MS) Quantification: Yes Sequence: H-HAEGTFTSDVSSYLEGQAA-Lys(Palmitoyl-gammaGlu)-EFIAWLVRGRG-OH